Intracranial pediatric aneurysms arising in children are rare. The treatment of these lesions requires both an understanding of their unique features as well as surgical, interventional, and pediatric critical care expertise offered through a multidisciplinary setting. The patient population, clinical presentation, complications, and trends in treatments are discussed in this article.
Intracranial aneurysms in children are rare; 0.5% to 4.6% of intracranial aneurysms occur in patients aged 18 years or younger. In a cooperative study reported in 1966, only 41 of 6368 (0.6%) ruptured aneurysms were found in patients younger than 19 years. Aneurysms occurring in very young children and infants are exceedingly rare. In adults, aneurysms are believed to form as a result of multiple risk factors (eg, family history, age older than 50 years, smoking, cocaine use, and hypertension) present over the course of an individual’s life span. In childhood, most of these aneurysmal risk factors do not exist, and for this reason, the pathogenesis is believed to be different. Some investigators have proposed that a vasculopathy predisposes regions of the cerebral vasculature to aneurysm formation. In multiple case series, primarily since the 1970s, pediatric aneurysms have been reported to exhibit features that differ from those in adults, such as male predominance, a higher incidence in locations such as the posterior circulation and internal carotid bifurcation, and greater numbers of giant aneurysms.
Discrepancies exist in the clinical description of pediatric aneurysms, likely related to the small numbers reported in most case series. Since the comprehensive review by Huang, other case series (including from the authors’ institution) have been published. Data from these larger series have confirmed some earlier findings and have contradicted others. It is likely that considerable heterogeneity exists with respect to the pathology, diagnosis, and treatment of these lesions.
The past 20 years have witnessed a gradual shift from exclusively surgical approaches toward endovascular treatment and multimodality therapeutic plans. The increasing number of options available for the treatment of complex aneurysms suggest that treatment should be guided by the best available evidence and executed by centers with expertise in each of these therapeutic tools.
Clinical presentation
As in adults, children with intracranial aneurysms can present with subarachnoid hemorrhage (SAH), headache, direct compressive effects, focal neurologic deficits, or seizures. If SAH is present, nearly 60% of patients will have a cerebral aneurysm. Fusiform aneurysms tend to present with nonhemorrhagic deficits. Many patients (30%–85%) with SAH confirmed by radiographic imaging or lumbar puncture typically present good clinical function defined by a Hunt and Hess grade between 1 and 3. Patients with poor clinical function have a Hunt and Hess grade of 4 to 5, occurring 15% to 42% of the time ( Table 1 ). The reason for the better clinical grade at presentation is unclear but may be because of several factors, such as fewer comorbidities, clouding the initial diagnosis, and a greater tendency to refer cerebrovascular cases to tertiary centers. Specific biologic features such as the activity of the nitric oxide synthase pathway and the robustness of leptomeningeal arterial collaterals may also play a role.
Year | Authors | Cases (n) | Boys (%) a | Girls (%) a | SAH (%) | Good Grade (%) | Poor Grade (%) | Giant (%) | ICA Terminus (%) | Posterior Circulation (%) | Surgical or Endovascular Treatment (%) | Good Outcome (%) | Death (%) | Years of Follow-Up |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1939 | McDonald and Korb | 61 | 60 | 34 | 87 | a | a | a | 16 | 23 | a | a | a | a |
1940–64 | Case reports | 9 | 78 | 22 | 100 | 22 | 78 | 11 | 22 | 22 | 33 | 33 | 66 | a |
1963 | Stehbens | 3 | 33 | 66 | 33 | 0 | 100 | a | a | a | a | a | 100 | a |
1965–1990 | Case reports | 35 | a | a | a | a | a | a | a | a | 67 | 25 | 75 | a |
1965 | Matson | 13 | 92 | 8 | 92 | a | a | a | 8 | 15 | 92 | 62 | 23 | 0–12 |
1966 | Locksley et al | 41 | 73 | 27 | 100 | a | a | a | 15 | 17 | a | a | a | a |
1971 | Patel and Richardson | 58 | 55 | 45 | 100 | 69 | 31 | 0 | 34 | 5 | 64 | 52 | 31 | 1–22 |
1973 | Sedzimir and Robinson | 50 | 56 | 44 | 100 | a | a | a | 36 | 4 | 50 | 70 | 28 | 2–15 |
1975 | Amacher and Drake | 16 | 69 | 31 | 88 | 44 | 44 | 44 | 13 | 31 | 69 | 56 | 38 | a |
1977 | Almeida et al | 11 | 55 | 45 | 91 | 82 | 18 | 0 | 55 | 9 | 91 | 64 | 27 | 0–15 |
1978 | Batnitzky and Muller | 12 | 67 | 31 | 83 | a | a | 25 | 25 | 25 | a | a | 25 | a |
1980 | Gerosa et al | 15 | 67 | 33 | 80 | 87 | 13 | 20 | 33 | 0 | 100 | 67 | 13 | 2–22 |
1981 | Heiskanen and Vikki | 32 | 53 | 47 | 100 | a | a | a | 50 | 6 | 100 | 75 | 6 | 0.5–11 |
1981 | Amacher et al | 26 | 62 | 38 | 65 | 96 | 4 | a | a | a | 96 | 92 | 4 | a |
1982 | Storrs et al | 29 | 45 | 55 | 76 | 38 | 62 | 31 | 31 | 31 | 72 | 45 | 34 | a |
1983 | Schauseil-Zipf et al | 15 | 67 | 33 | 60 | 20 | a | a | a | 7 | 80 | 13 | 33 | 1–17 |
1983 | Ostergaard and Voldby | 43 | 58 | 42 | 77 | 72 | 28 | 5 | 44 | 7 | 81 | 53 | 30 | 0.25–14 |
1985 | Humphreys et al | 35 | a | a | 74 | 11 | 63 | 29 | 26 | 20 | 66 | 40 | 40 | a |
1986 | Pasqualin et al | 31 | a | a | 94 | a | a | 3 | 29 | 3 | 61 | 52 | 3 | a |
1988 | Roche et al | 43 | 70 | 30 | 81 | a | a | 7 | 26 | 16 | 95 | 79 | 12 | a |
1989 | Meyer et al | 24 | 71 | 25 | 54 | 50 | 4 | 54 | 8 | 46 | 100 | 92 | 4 | 1–7 |
1991–2002 | Case reports | 47 | a | a | a | a | a | a | a | a | 70 | 63 | 26 | 0–19 |
1991 | Herman et al | 16 | 56 | 44 | 63 | 38 | 6 | 19 | 6 | 19 | 94 | 75 | 6 | 0.67–6 |
2001 | Proust et al | 22 | 73 | 27 | 95 | 59 | 36 | 14 | 36 | 9 | 100 | 64 | 23 | a |
2004 | Huang et al | 19 | 68 | 32 | 58 | 42 | 16 | 37 | 11 | 42 | 84 | 95 | 5 | 0.1–9 |
2005 | Lasjaunias et al | 59 | 59 | 41 | 50 | 30 | 18 | 4 | 27 | 67 | 52 | 10 | 0–6 | |
2005 | Agid et al | 33 | 16 | 17 | 9 | a | a | 30 | 22 | 30 | 70 | 64 | 15 | 12 |
2005 | Krishna et al | 22 | 64 | 36 | 91 | 68 | 32 | 13.6 | 20 | 24 | 77 | 82 | 10 | 0.1–2.5 |
2006 | Sanai et al | 32 | 44 | 56 | 22 | 85 | 15 | 40 | 13 | 28 | 90 | 78 | 0 | 6 |
2008 | Vaid et al | 36 | 52 | 48 | 92 | 58 | 42 | 21 | 18 | 30 | 75 | 78 | 11 | 0.1–3.5 |
2009 | Hetts et al | 77 | 52 | 48 | 32 | a | a | 11 | a | 22 | 77 | a | 1 | a |
Total | 965 | 60 | 37 | 74 | 51 | 34 | 21 | 24 | 19 | 79 | 62 | 24 |

Stay updated, free articles. Join our Telegram channel

Full access? Get Clinical Tree


